U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
CERGUTUZUMAB
USAN  
USAN  
Official Name English
CERGUTUZUMAB [USAN]
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) (HUMAN MONOCLONAL MAB<CEA> HEAVY CHAIN 1 (HOLE)), DISULFIDE WITH HUMAN MONOCLONAL MAB<CEA> LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) (HUMAN MONOCLONAL MAB<CEA
Systematic Name English
Code System Code Type Description
CAS
1622305-37-6
Created by admin on Tue Apr 01 19:44:21 GMT 2025 , Edited by admin on Tue Apr 01 19:44:21 GMT 2025
PRIMARY
FDA UNII
O2IF0511E8
Created by admin on Tue Apr 01 19:44:21 GMT 2025 , Edited by admin on Tue Apr 01 19:44:21 GMT 2025
PRIMARY
NCI_THESAURUS
C174781
Created by admin on Tue Apr 01 19:44:21 GMT 2025 , Edited by admin on Tue Apr 01 19:44:21 GMT 2025
PRIMARY
USAN
DE-102
Created by admin on Tue Apr 01 19:44:21 GMT 2025 , Edited by admin on Tue Apr 01 19:44:21 GMT 2025
PRIMARY
SMS_ID
100000181740
Created by admin on Tue Apr 01 19:44:21 GMT 2025 , Edited by admin on Tue Apr 01 19:44:21 GMT 2025
PRIMARY
ACTIVE MOIETY
CERGUTUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966